Reported online last week in Science Translational Medicine, researchers at MIT and Harvard used nanoparticles to demonstrate the nanoparticles that target a protein called ID4 can reduce ovarian cancer tumors in mice.
Researchers hope that this approach could help speed the development of new drugs. As new technology allows researchers to sequence cancer cell genomes, researchers are finding more and more gene mutations and deletions that may be therapeutic targets. This approach—using a mouse model to determine which ones are important—may help researchers prioritize which ones to focus drug development efforts on.
Click here for the abstract.